Pipeline
Aldeyra is a well-capitalized biotechnology company with a broad pipeline focused on immune-mediated disease.
Topical ocular administration
(Option agreement w/AbbVie)
Dry Eye Disease
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- NDA
Topical ocular administration
(Option agreement w/AbbVie)
Allergic Conjunctivitis
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- NDA
Intravitreal injection
Dry Age-Related Macular Degeneration / Geographical Atrophy
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- NDA
ADX-2191*
Intravitreal injection
Primary Vitreoretinal Lymphoma
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- NDA
*U.S. FDA Orphan-Drug Designated